CTRI/2013/10/004048进行中（未招募）3 期
A 24-week Randomized, Open-label, Study To Evaluate The Safety And Efficacy Of Fesoterodine In Subjects Aged 6 To 17 Years With Symptoms Of Detrusor Overactivity Associated With A Neurological Condition (Neurogenic Detrusor Overactivity) - Nil
试验速览
- 阶段
- 3 期
- 状态
- 进行中（未招募）
- 发起方
- Pfizer Inc
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Male or female subjects aged 6-17 years 11 months
- •Subjects with stable neurological disease and neurogenic detrusor overactivity
- •Evidence of a personally signed and dated informed consent document In addition, an assent from the subject will be obtained when appropriate, and when the potential subject is capable of providing assent.
排除标准
- •Concomitant medications which may increase the risk to subjects or confound study results
- •Other medical conditions which may increase the risk to subjects or confound study results
- •Contraindications to the use of fesoterodine or oxybutynin
研究者
相似试验
进行中（未招募）
1 期
A clinical research study to find out how the medicine fesoterodine works in children aged 6 to 17 years with bladder overactivity caused by a neurological condition (such as spina bifida).eurogenic Detrusor Overactivity (NDO).MedDRA version: 20.0Level: PTClassification code 10029279Term: Neurogenic bladderSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2010-022475-55-LTPfizer Inc.235 East 42nd Street, New York, NY 10017194
进行中（未招募）
1 期
A clinical research study to find out how the medicine fesoterodine works in children aged 6 to 17 years with bladder overactivity caused by a neurological condition (such as spina bifida).EUCTR2010-022475-55-DKPfizer Inc.235 East 42nd Street, New York, NY 10017186
进行中（未招募）
1 期
A clinical research study to find out how the medicine fesoterodine works in children aged 6 to 16 years with bladder overactivity caused by a neurological condition (such as spina bifida).EUCTR2010-022475-55-FIPfizer Inc.235 East 42nd Street, New York, NY 10017118
进行中（未招募）
1 期
A clinical research study to find out how the medicine fesoterodine works in children aged 6 to 17 years with bladder overactivity caused by a neurological condition (such as spina bifida).EUCTR2010-022475-55-NLPfizer Inc.235 East 42nd Street, New York, NY 10017181
进行中（未招募）
1 期
A clinical research study to find out how the medicine fesoterodine works in children aged 6 to 17 years with bladder overactivity caused by a neurological condition (such as spina bifida).eurogenic Detrusor Overactivity (NDO).MedDRA version: 20.0Level: PTClassification code 10029279Term: Neurogenic bladderSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2010-022475-55-SEPfizer Inc.235 East 42nd Street, New York, NY 10017186